Table 1 Demographic data for the patients and healthy individuals in Testing and Validation Cohorts
Groups | Validation Cohort | |||||||
|---|---|---|---|---|---|---|---|---|
n | Gender | Age [years, median (range)] | n | Gender | Age [years, median (range)] | |||
Male | Female | Male | Female | |||||
Early HCC | 314 | 275 | 39 | 49 (20–78) | 158 | 142 | 16 | 50 (22–78) |
Chronic Liver Disease | 300 | 222 | 78 | 44 (17–83) | 120 | 96 | 24 | 43 (17–77) |
Metastatic Liver Cancers | 16 | 8 | 8 | 59 (23–75) | 12 | 7 | 5 | 61 (25–75) |
Benign Liver Tumors | 19 | 12 | 7 | 49 (14–63) | 14 | 9 | 5 | 47 (15–65) |
Healthy individuals | 432 | 221 | 211 | 22 (18–54) | 172 | 83 | 89 | 21 (18–53) |